More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

BACKGROUND: More than ever, clinicians need regularly updated reviews given the
continuously increasing amount of new information regarding innovative cervical cancer …

Prophylactic vaccination against high risk human papilloma virus (HPV) 16 and 18
represents an exciting means of protection against HPV related malignancy. However, this …

The recognition of a strong etiological relationship between infection with high-risk human
papillomavirusses and cervical cancer has prompted research to develop and evaluate …

Human Papillomavirus (HPV) vaccines will likely have an impact as a preventive strategy for
cervical cancer. Screening for precancerous lesions cannot be discontinued because …

A wealth of evidence has led to the conclusion that virtually all cases of cervical cancer are
attributable to persistent infection by a subset of human papillomavirus (HPV) types …

Organized and opportunistic screening programs for cervical cancer have been very
successful in many developed countries with reductions in squamous cell cervical cancer …

Cervical cancer control includes primary prevention through vaccination to prevent human
papillomavirus (HPV) infection and secondary prevention through screening to detect and …

The recognition that infection with certain human papillomavirus (HPV) types is a necessary
cause of cervical cancer has opened new fronts for the prevention of this disease. Primary …

Cytologic screening has greatly reduced the incidence of invasive cervical cancer in many
industrialized nations. State-of-the-art cervical cancer prevention is costly, however, and …